Results 101 to 110 of about 217,588 (352)
PLoS ONE, 2014 Our previous study showed that three rapeseed protein-derived peptides (TF, LY and RALP) inhibited the in vitro activities of angiotensin converting enzyme (ACE) and renin.
Rong He, R. Aluko, Xingrong Ju
semanticscholar +1 more source
Socio‐economic status and the effect of guideline‐directed medical therapy in the STRONG‐HF study
ESC Heart Failure, EarlyView.Abstract Aims Acute heart failure (AHF) impacts millions globally, with outcomes varying based on socio‐economic status (SES). Methods SES measured by annual household income, years of education and medical insurance coverage. Each patient's income and education level relative to the median or mean, respectively, in the country was calculated, and ...
Albertino Damasceno +29 more
wiley +1 more source
European Journal of Heart Failure, Volume 24, Issue 11, Page 2152-2161, November 2022., 2022 Triple guideline‐directed medical therapy (GDMT) prescription was associated with a lower 2‐year mortality compared to non‐triple GDMT prescription (A). Such association was observed in patients with concomitant comorbidities (B). CI, confidence interval; CKD, chronic kidney disease; CMP, cardiomyopathy; HR, hazard ratio; MRA, mineralocorticoid ...
Satoshi Higuchi +36 more
wiley +1 more source
Терапевтический архив, 2011 Recent revolution in the knowledge about structure, physiological and pathophysiological effects of renin-angiotensin-aldosteron system (RAAS) took place recently when it was discovered that local synthesis of all the RAAS components occurs in target ...
Marina Vladimirovna Shestakova +1 more
doaj
British medical journal, 2013 Objective To compare the long term efficacy and adverse events of dual blockade of the renin-angiotensin system with monotherapy. Design Systematic review and meta-analysis.
Harikrishna Makani +4 more
semanticscholar +1 more source
European Journal of Heart Failure, Volume 24, Issue 11, Page 2185-2195, November 2022., 2022 Patients with heart failure and chronic kidney disease are less likely to receive and persist on guideline‐recommended medical therapies. Aim Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management.
Roemer J. Janse +9 more
wiley +1 more source
The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
Journal of Managed Care Pharmacy, 2007 BACKGROUND: The renin-angiotensin aldosterone system (RAAS) is a hormonal cascade that functions in the homeostatic control of arterial pressure, tissue perfusion, and extracellular volume.
S. Atlas
semanticscholar +1 more source
Serum Renin and Renin Substrate Levels in Scleroderma
Experimental Biology and Medicine, 1975 Scleroderma is a disease of mesenchymal tissues characterized by fibrosis and vascular changes which eventually lead to organ insufficiency. Two clinical forms have been recognized, localized and systemic scleroderma. The localized form only affects the skin and the lesions have a tendency to resolve spontaneously. Systemic scleroderma is a progressive,
Anne B. Gould, Raul Fleischmajer
openaire +3 more sources
ESC Heart Failure, EarlyView.Abstract Aims Renin–angiotensin–aldosterone system inhibitors (RAASi) are foundational in the management of heart failure (HF) and chronic kidney disease (CKD) but increase the risk of hyperkalaemia. To facilitate continuation of RAASi therapy, guidelines suggest managing hyperkalaemia using newer potassium binders such as sodium zirconium ...
Charles V. Pollack Jr. +9 more
wiley +1 more source
European Journal of Heart Failure, Volume 24, Issue 11, Page 2175-2184, November 2022., 2022 Aim To evaluate short‐term changes in tricuspid regurgitation (TR) after transcatheter edge‐to‐edge mitral valve repair (M‐TEER) in secondary mitral regurgitation (SMR), their predictors and impact on mortality. Methods and results This is a retrospective analysis of SMR patients undergoing successful M‐TEER (post‐procedural mitral regurgitation ≤2 ...
Marianna Adamo +41 more
wiley +1 more source